Maryland § 12-6A-06

§ 12-6A-06.

    (a)    A protocol under this subtitle:

        (1)    May authorize:

            (i)    For protocols by a licensed physician and licensed pharmacist, the initiation of drug therapy under written, disease–state specific protocols;

            (ii)    The modification, continuation, and discontinuation of drug therapy under written, disease–state specific protocols;

            (iii)    The ordering of laboratory tests; and

            (iv)    Other patient care management measures related to monitoring or improving the outcomes of drug or device therapy; and

        (2)    May not authorize acts that exceed the scope of practice of the parties to the therapy management contract.

    (b)    A protocol shall prohibit the substitution of a chemically dissimilar drug product by the pharmacist for the product prescribed by the authorized prescriber, unless permitted in the therapy management contract.